Korean J Fam Pract. 2018; 8(6): 848-854  https://doi.org/10.21215/kjfp.2018.8.6.848
The Efficacy and Safety of Black Tea Extract on Weight or Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
Soo Jin Kim1, Kyung Soo Kim1,*, Myeong Soo Lee2, Eung Nam An3, Ji-Youn Kim4, Tae Ho Lee5, Namjoon Baek5, Sangjin Lee5,6
1Department of Family Medicine, College of Medicine, The Catholic University of Korea, Seoul; 2Korean Medicine Life Science, University of Science &
Technology, Daejeon; 3College of Sport Science, Sungkyunkwan University, Suwon; 4Exercise Rehabilitation Convergence Institute, Gachon University, Incheon;
5Dong-A Pharm Research Institute, Pharmaceutical Product Research Laboratories, Yongin; 6School of Pharmacy, Sungkyunkwan University, Suwon, Korea
Kyung Soo Kim
Tel: +82-2-2258-2895, Fax: +82-2-2258-2896
E-mail: kskim@catholic.ac.kr
ORCID: http://orcid.org/0000-0003-3501-1212
Received: August 25, 2017; Revised: September 19, 2017; Accepted: October 7, 2017; Published online: December 20, 2018.
© The Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: Black tea extracts (BTE), which are rich in gallic acid, have been associated with the improvement of obesity in rats. However, whether black tea consumption is beneficial in human subjects is unknown. In this study, we aimed to evaluate whether BTE can reduce body fat mass in human subjects.
Methods: We investigated the effects of BTE intake in 50 pre-obese and obese Korean adults (23 kg/m2 Results: After 8 weeks of BTE consumption the mean BMI decreased by 0.05±0.32 kg/m2 in the BTE group compared with a decrease of 0.18±0.78 kg/m2 in the placebo group. There was a 0.10±0.79 kg difference in weight within the BTE group. Abdominal computed tomography scans revealed a liver Hounsfield unit decrease of 0.32±5.84 in the BTE group compared with a decrease of 3.03±3.65 in the placebo group. None of the differences were statistically significant (P>0.05).
Conclusion: BTE was not effective in reducing human body weight or body fat composition, when compared with the effects of placebo.
Keywords: Black Tea Extract; Obesity; Body Mass Index; Visceral Fat
  1. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001; 104: 531-43.
  2. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106:473-81.
    Pubmed KoreaMed CrossRef
  3. Fujita H, Yamagami T. Efficacy and safety of Chinese black tea (Pu-Ehr) extract in healthy and hypercholesterolemic subjects. Ann Nutr Metab 2008;53: 33-42.
    Pubmed CrossRef
  4. Tsuchida T, Itakura H, Nakamura H. Reduction of body fat in humans by long-term ingestion of catechins. Prog Med 2002; 22: 2189-203.
  5. Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao H, Takeo T, et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1992; 1127: 141-6.
  6. Toris T, Satoh Y, Fujita H, Nagaoka T, Kawabata J. The structure and activity of Yunnan fermented tea on mixed bile salt micelles. Nippon Nougeikagakukaisi 2007; (suppl): 261.
  7. Fujita H, Yamagami T. Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res 2008; 28: 450-6.
    Pubmed CrossRef
  8. Uchiyama S, Taniguchi Y, Saka A, Yoshida A, Yajima H. Prevention of dietinduced obesity by dietary black tea polyphenols extract in vitro and in vivo. Nutrition 2011; 27: 287-92.
    Pubmed CrossRef
  9. Kubota K, Sumi S, Tojo H, Sumi-Inoue Y, I-Chin H, Oi Y, et al. Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract. Nutr Res 2011; 31: 421-8.
    Pubmed CrossRef
  10. Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Semin Liver Dis 2001; 21: 71-80.
  11. Boyce CJ, Pickhardt PJ, Kim DH, Taylor AJ, Winter TC, Bruce RJ, et al. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 2010; 194: 623-8.
    Pubmed CrossRef
  12. Speliotes EK, Massaro JM, Hoffmann U, Foster MC, Sahani DV, Hirschhorn JN, et al. Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 2008; 23: 894-9.
    Pubmed KoreaMed CrossRef
  13. Azuma K, Kadowaki T, Cetinel C, Kadota A, El-Saed A, Kadowaki S, et al. Higher liver fat content among Japanese in Japan compared with non-Hispanic whites in the United States. Metabolism 2009; 58: 1200-7.
    Pubmed KoreaMed CrossRef
  14. Machin D, Campbell MJ. Design of studies for medical research. Hoboken (NJ): John Wiley & Sons; 2005.
  15. Ballarè M, Campanini M, Airoldi G, Zaccala G, Bertoncelli MC, Cornaglia G, et al. Hepatotoxicity of hydroxy-methyl-glutaryl-coenzyme A reductase inhibitors. Minerva Gastroenterol Dietol 1992; 38: 41-4.
  16. Pierno S, De Luca A, Tricarico D, Roselli A, Natuzzi F, Ferrannini E, et al. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. J Pharmacol Exp Ther 1995; 275: 1490-6.
  17. Tal A, Rajeshawari M, Isley W. Rhabdomyolysis associated with simvastatingemfibrozil therapy. South Med J 1997; 90: 546-7.
    Pubmed CrossRef
  18. Fujita H, Yamagami T. Extract of black tea (pu-ehr) inhibits postprandial rise in serum cholesterol in mice, and with long term use reduces serum cholesterol and low density lipoprotein levels and renal fat weight in rats. Phytother Res 2008; 22: 1275-81.
    Pubmed CrossRef
  19. Yoshino K, Hara Y, Sano M, Tomita I. Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol Pharm Bull 1994; 17: 146-9.
    Pubmed CrossRef
  20. Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med 2010; 363: 245-56.
    Pubmed CrossRef

This Article

Author ORCID Information

Funding Information

Social Network Service